EVIDENCE OF REDUCTION IN HEPATIC, CARDIAC AND PITUITARY IRON STORES IN PATIENTS WITH THALASSEMIA MAJOR DURING LONG-TERM THERAPY WITH THE ORALLY-ACTIVE IRON-CHELATING AGENT L1
Nf. Olivieri et al., EVIDENCE OF REDUCTION IN HEPATIC, CARDIAC AND PITUITARY IRON STORES IN PATIENTS WITH THALASSEMIA MAJOR DURING LONG-TERM THERAPY WITH THE ORALLY-ACTIVE IRON-CHELATING AGENT L1, Blood, 84(10), 1994, pp. 10000109-10000109